CN116023289A - Avocado oil ceramide and synthesis method and application thereof - Google Patents
Avocado oil ceramide and synthesis method and application thereof Download PDFInfo
- Publication number
- CN116023289A CN116023289A CN202310051748.3A CN202310051748A CN116023289A CN 116023289 A CN116023289 A CN 116023289A CN 202310051748 A CN202310051748 A CN 202310051748A CN 116023289 A CN116023289 A CN 116023289A
- Authority
- CN
- China
- Prior art keywords
- ceramide
- acid
- avocado oil
- weight percent
- sphingosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940106189 ceramide Drugs 0.000 title claims abstract description 181
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 title claims abstract description 166
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 title claims abstract description 166
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 title claims abstract description 166
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 title claims abstract description 164
- 239000008163 avocado oil Substances 0.000 title claims abstract description 106
- 235000021302 avocado oil Nutrition 0.000 title claims abstract description 104
- 238000001308 synthesis method Methods 0.000 title description 4
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 53
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 52
- 239000000194 fatty acid Substances 0.000 claims abstract description 52
- 229930195729 fatty acid Natural products 0.000 claims abstract description 52
- -1 sphingosine compound Chemical class 0.000 claims abstract description 35
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940033329 phytosphingosine Drugs 0.000 claims abstract description 15
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 claims abstract description 14
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 claims abstract description 12
- OTKJDMGTUTTYMP-UHFFFAOYSA-N dihydrosphingosine Natural products CCCCCCCCCCCCCCCC(O)C(N)CO OTKJDMGTUTTYMP-UHFFFAOYSA-N 0.000 claims abstract description 12
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 claims abstract description 10
- 230000008591 skin barrier function Effects 0.000 claims abstract description 10
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 8
- 230000035876 healing Effects 0.000 claims abstract description 8
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 6
- 239000002537 cosmetic Substances 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 5
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims description 38
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 235000021319 Palmitoleic acid Nutrition 0.000 claims description 19
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims description 19
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 18
- 239000005642 Oleic acid Substances 0.000 claims description 17
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 16
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 16
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 16
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 16
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 235000021314 Palmitic acid Nutrition 0.000 claims description 15
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 15
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 13
- 235000020778 linoleic acid Nutrition 0.000 claims description 13
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 13
- 235000021355 Stearic acid Nutrition 0.000 claims description 11
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 11
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 11
- 229960004488 linolenic acid Drugs 0.000 claims description 11
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 11
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 11
- 239000008117 stearic acid Substances 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 9
- 102000008186 Collagen Human genes 0.000 claims description 9
- 108010035532 Collagen Proteins 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- 229920001436 collagen Polymers 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 8
- 230000003078 antioxidant effect Effects 0.000 claims description 8
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 8
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 8
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 8
- 230000008439 repair process Effects 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 206010051246 Photodermatosis Diseases 0.000 claims description 7
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 7
- 230000002087 whitening effect Effects 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 102000016942 Elastin Human genes 0.000 claims description 6
- 108010014258 Elastin Proteins 0.000 claims description 6
- 229920002549 elastin Polymers 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 230000035899 viability Effects 0.000 claims description 3
- 235000005911 diet Nutrition 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- OTKJDMGTUTTYMP-ROUUACIJSA-N Safingol ( L-threo-sphinganine) Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ROUUACIJSA-N 0.000 claims 1
- OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 19
- 239000000047 product Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 150000001783 ceramides Chemical class 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 102000016387 Pancreatic elastase Human genes 0.000 description 9
- 108010067372 Pancreatic elastase Proteins 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 238000004809 thin layer chromatography Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 7
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 150000003410 sphingosines Chemical class 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000002158 endotoxin Substances 0.000 description 5
- 229920006008 lipopolysaccharide Polymers 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 4
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
- 235000021466 carotenoid Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- 238000006482 condensation reaction Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 150000002066 eicosanoids Chemical class 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 229940031439 squalene Drugs 0.000 description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
- 244000025272 Persea americana Species 0.000 description 3
- 235000008673 Persea americana Nutrition 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 239000012159 carrier gas Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- FIXXCHAZHOXPQG-ZNWYJMOFSA-N (E,2S,3R)-2-aminooctadec-4-ene-1,3-diol octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO FIXXCHAZHOXPQG-ZNWYJMOFSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000036564 melanin content Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 235000002378 plant sterols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000037072 sun protection Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention belongs to the technical field of biological medicines, and discloses avocado oil ceramide which is obtained by reacting avocado oil fatty acid with a sphingosine compound, wherein the sphingosine compound is selected from sphingosine, phytosphingosine and sphinganine. The avocado oil ceramide has excellent performances in the aspects of repairing natural skin barriers, anti-inflammatory, tissue healing, anti-aging and the like, and has wide application prospects in the fields of cosmetics, health-care products, biological medicines and the like.
Description
Technical Field
The invention belongs to the technical field of biological medicines, and particularly relates to avocado oil ceramide and a synthesis method and application thereof.
Background
Ceramides (ceramides, also known as molecular nails) naturally occur in the skin and are very important components of the skin barrier (stratum corneum), in amounts of up to 40-50 wt.%, ceramides are a class of sphingolipids consisting of long-chain bases of sphingosine and fatty acids, in which the carbon chain length, unsaturation and number of hydroxyl groups of the sphingosine moiety, fatty acid moiety are all variable, and ceramides represent a class of compounds. Ceramide has excellent properties in regulating skin barrier function, recovering skin moisture, enhancing adhesion between skin keratinocytes, and the like.
Because of the importance of ceramides, many cosmetic and pharmaceutical companies are researching and developing corresponding products. The natural plant-derived ceramide can form an effective skin barrier to prevent water loss and resist external damage due to the more sustainable and more environment-friendly raw material source and the characteristics similar to the skin ceramide components, and can become a next-generation environment-friendly, safe and reliable ceramide product.
Avocado oil, also known as avocado oil, obtained from the flesh of avocados, is one of a few non-seed-made vegetable oils. The avocado oil has rich nutritive value, contains abundant healthy fat (unsaturated fatty acid reaches about 80 wt%), and also contains nutrients required by human body: vitamin a, vitamin D, vitamin E, vitamin K, carotenoids, plant sterols, squalene, etc. The avocado oil can be used for supplementing nutrition, reducing blood pressure, reducing weight, improving blood lipid, preventing cardiovascular and cerebrovascular diseases, and promoting health of diabetes. The avocado oil has wide application in the field of skin care and beauty, is particularly suitable for dry skin and aged skin, has the function of filtering ultraviolet rays, and has good sun protection effect. The avocado oil can be used alone or in combination; can be used for external or oral administration, or used as cooking oil for heating. The fatty acids of avocado oils are mainly oleic acid, linoleic acid and less common palmitoleic acid. The combination of the three unsaturated fatty acids ensures that avocado oil is easily absorbed on the skin to achieve the best care effect and ensure skin moistening. The high levels of phytosterols, such as beta-sitosterol, in avocado oil form a natural sun protection factor which helps to protect the skin from sunlight and also relieves skin discomfort due to sunburn. In addition, the components such as multiple vitamins, carotenoid, squalene and the like are excellent blocking agents, inhibitors and antioxidants, and can protect skin from being influenced by environmental factors such as ultraviolet rays, sunlight and the like under the combined action of the blocking agents, the inhibitors and the antioxidants, so that the effect of preventing skin cancer is achieved.
Disclosure of Invention
The invention aims to provide ceramide synthesized by using avocado oil fatty acid of plant origin.
It is another object of the present invention to provide a method for synthesizing avocado oil ceramide which utilizes avocado oil or avocado fatty acid which are naturally derived and readily available from plants as raw materials.
It is another object of the present invention to provide the use of avocado oil ceramide.
In order to achieve one of the above purposes, the present invention adopts the following technical scheme:
in a first aspect of the invention, avocado oil ceramide is obtained by reacting avocado oil fatty acids with a sphingoid compound selected from the group consisting of sphingosine, phytosphingosine, sphinganine.
The reaction can be chemical synthesis reaction (as detailed below), or microbial fermentation method, i.e. using Pichia pastoris or Saccharomyces cerevisiae, fermenting under certain environment to obtain sphingosine compound, and adding fatty acid to obtain ceramide; or using avocado oil as raw material, selecting proper strain, and fermenting to obtain avocado oil ceramide.
Sphingosine refers to 2-amino-4-octadecene-1, 3-diol, phytosphingosine refers to 2-amino-octadecane-1, 3, 4-triol, and dihydrosphingosine refers to 2-amino-octadecane-1, 3-diol.
Further, the avocado oil fatty acid is obtained by hydrolyzing avocado oil.
Further, the avocado oil fatty acid contains 50 to 80wt% oleic acid.
Further, the avocado oil fatty acid contains 5 to 25wt% palmitoleic acid.
Further, the avocado oil fatty acid contains 5 to 20wt% linoleic acid.
Further, the avocado oil fatty acid contains 6 to 18wt% palmitic acid.
Further, the avocado oil fatty acid contains 0.1 to 2wt% stearic acid.
Further, the avocado oil fatty acid contains 0.1 to 1wt% linolenic acid.
In addition, avocado oil fatty acids also contain 0 to 1wt% of eicosapentaenoic acid (i.e. arachidonic acid) 0 to 0.5 wt%.
The avocado oil fatty acid comprises the following components: 50 to 80 weight percent of oleic acid, 5 to 25 weight percent of palmitoleic acid, 5 to 20 weight percent of linoleic acid, 6 to 18 weight percent of palmitic acid, 0.1 to 2 weight percent of stearic acid, 0.1 to 1 weight percent of linolenic acid, 0 to 1 weight percent of arachic acid and 0 to 0.5 weight percent of eicosapentaenoic acid.
The main component of avocado oil fatty acid is oleic acid, other fatty acids including palmitoleic acid, linoleic acid, palmitic acid, stearic acid and linolenic acid are essential components, and are influenced by tree species, soil, climate, production place, picking season and extraction process, the content of each component is different, and eicosanoic acid are not necessarily contained, and are optional components or unnecessary components.
Avocado oil ceramide, which comprises the following components: oleic acid ceramide, palmitoleic acid ceramide, linoleic acid ceramide, palmitic acid ceramide, stearic acid ceramide, linolenic acid ceramide; since fatty acids all participate in the same reaction, the mass ratio of ceramide after the reaction does not change much, so the composition of avocado oil ceramide is similar to that of avocado oil fatty acid: 50 to 80 weight percent of oleic acid ceramide, 5 to 25 weight percent of palmitoleic acid ceramide, 5 to 20 weight percent of linoleic acid ceramide, 6 to 18 weight percent of palmitic acid ceramide, 0.1 to 2 weight percent of stearic acid ceramide and 0.1 to 1 weight percent of linolenic acid ceramide. The content of each component is different due to the different content of each fatty acid in avocado oil fatty acid or grease. In addition, the avocado oil ceramide also comprises ceramide obtained by the reaction of one or more of eicosanoids and eicosanoids with sphingosine compounds, namely 0 to 1 weight percent of eicosanoids ceramide and 0 to 0.5 weight percent of eicosanoids ceramide. Avocado oil ceramide also includes compounds that are present in avocado oil fatty acids but do not react with sphingosine compounds, such as vitamin a, vitamin D, vitamin E, vitamin K, carotenoids, phytosterols, squalene, and the like.
Avocado oil ceramide, which comprises the following components: oleic acid ceramide, palmitoleic acid ceramide, linoleic acid ceramide, palmitic acid ceramide; 50-80 wt% of oleic acid ceramide, 5-25 wt% of palmitoleic acid ceramide, 5-20 wt% of linoleic acid ceramide and 6-18 wt% of palmitoleic acid ceramide.
Further, the avocado oil ceramide comprises stearic acid ceramide, and the stearic acid ceramide accounts for 0.1-2 wt%.
Further, the avocado oil ceramide comprises linolenic acid ceramide, and the linolenic acid ceramide accounts for 0.1 to 1 weight percent.
Further, avocado oil ceramides include not more than 1% by weight of eicosapentaenoic acid ceramides and not more than 0.5% by weight of eicosapentaenoic acid ceramides, and in particular, 0.1 to 1% by weight of eicosapentaenoic acid ceramides and 0.1 to 0.5% by weight of eicosapentaenoic acid ceramides.
Oleic acid ceramide is obtained by condensation reaction of oleic acid and sphingosine compounds, and comprises oleic acid phytosphingosine ceramide, oleic acid sphingosine ceramide and oleic acid dihydrosphingosine ceramide; palmitoleic acid ceramide is obtained by condensation reaction of palmitoleic acid and sphingosine compounds, and comprises palmitoleic acid phytosphingosine ceramide, palmitoleic acid sphingosine ceramide and palmitoleic acid dihydrosphingosine ceramide; the linoleic acid ceramide is obtained by condensation reaction of linoleic acid and sphingosine compounds, and comprises linoleic acid phytosphingosine ceramide, linoleic acid sphingosine ceramide and linoleic acid dihydrosphingosine ceramide; the palmitic acid ceramide is obtained by condensation reaction of palmitic acid and sphingosine compounds, and comprises palmitic acid phytosphingosine ceramide, palmitic acid sphingosine ceramide and palmitic acid dihydrosphingosine ceramide; stearic acid ceramide, linolenic acid ceramide, arachidic acid ceramide, eicosapentaenoic acid ceramide, and the like.
In a second aspect of the invention, a method for synthesizing avocado oil ceramide comprises the following steps:
under the conditions of condensing agent and organic base, the avocado oil fatty acid reacts with sphingosine compound, the condensing agent is EDCI, and the organic base is Et 3 N。
Further, the avocado oil fatty acid, sphingosine, EDCI, et 3 The molar ratio of N is 1: (1-1.5): (1-2): (1-2), wherein the solvent for the reaction is at least one of dichloromethane, tetrahydrofuran, ethyl acetate and acetonitrile.
Avocado oils purchased on the market are generally in the form of oils and fats, which need to be hydrolysed to fatty acids of the avocado oil, and therefore comprise the following steps:
the avocado oil fat is hydrolyzed by saponification reaction to obtain avocado oil fatty acid.
Further, the saponification reaction is hydrolysis of avocado oil in potassium hydroxide solution.
Further, the mass ratio of the avocado oil and fat to the potassium hydroxide is 1: (1-2).
In a third aspect of the invention, the use of avocado oil ceramide in cosmetics, pharmaceutical products, dietary or health care products.
Further, the avocado oil ceramide has at least one of skin barrier repair, tissue healing, anti-aging, anti-inflammatory, anti-photoaging, antioxidant, collagen synthesis promoting, elastin activity maintaining, and whitening effects.
A composition comprising avocado oil ceramide, the composition having at least one of skin barrier repair, tissue healing, anti-aging, anti-inflammatory, anti-photoaging, antioxidant, promoting collagen synthesis, maintaining elastin viability, whitening efficacy.
The composition contains acceptable auxiliary materials, including one or more of solubilizer, antiseptic, antioxidant, pH regulator, penetration enhancer, liposome, humectant, thickener, chelating agent, skin feel regulator, surfactant, emulsifier, essence and pigment; the composition is in the form of cream, emulsion, solution, film, aerosol or spray.
The invention has the following beneficial effects:
the avocado oil fatty acid belongs to naturally-formed fatty acid, the main component is monounsaturated fatty acid-oleic acid, and the avocado oil fatty acid also contains palmitoleic acid, linoleic acid, palmitic acid and the like, and the avocado oil ceramide prepared by mild reaction with a sphingosine compound naturally existing in skin has excellent performance in the aspects of repairing a natural skin barrier, resisting oxidation, resisting aging and the like, and has wide application prospect in the fields of cosmetics, health-care products, biological medicines and the like.
1. Better results compared to ceramide alone. Different ceramides have different effects due to the structural differences, and ceramides with a single structure generally have difficulty in having comprehensive effects. The scheme is based on a bionic thought, and the natural avocado oil or fatty acid is used as a raw material to synthesize the compound ceramide so as to make up the difference of different ceramide effects, and trace fatty acid in the avocado oil can form trace ceramide to play a role in efficacy supplement.
2. Compared with the compounded ceramide, the effect is better. Besides fatty acid (or grease), the avocado oil also contains nutrients required by human body, such as vitamin A, vitamin D, vitamin E, vitamin K, carotenoid, plant sterol, squalene and the like, and the nutrients have the effects of moistening skin, filtering ultraviolet rays, providing barrier for skin and the like, and the ceramide synthesized by the avocado oil has a synergistic effect with other active ingredients contained in the avocado oil, and has better effect compared with the ceramide compounded according to similar proportion.
3. The cost is lower. The method of the invention can rapidly obtain a plurality of ceramide compound compositions, and the vegetable-derived avocado oil and fat or fatty acid thereof has wide sources, easy commercial acquisition, lower cost, environmental protection and economy, is different from the idea of mixing and compounding different single ceramides, and the fatty acid with a single component has high raw material price (such as palmitoleic acid), needs to respectively produce different ceramides, and then is compounded, thereby increasing the preparation cost.
4. The synthesis method is simple. The method can adopt chemical synthesis to realize one-step preparation of various ceramides, and can also use a microbial fermentation method.
Drawings
FIG. 1 is a graph showing the results of the cell migration ability test of example 4;
FIG. 2 is a bar graph of elastase inhibition of example 5;
FIG. 3 is a bar graph showing the detection of IL-6 factor expression level in anti-inflammatory repair efficacy of example 6;
FIGS. 4 and 5 are bar charts of MMP1 expression levels in the photo-aging test of example 7;
FIG. 6 is a bar graph of DPPH radical scavenging for oxidation resistance test of example 8;
fig. 7 is a bar graph of the whitening activity test melanin content of example 9.
Detailed Description
The invention will be further illustrated with reference to specific examples.
EDCI refers to 1-ethyl- (3-dimethylaminopropyl) carbodiimide, et 3 N refers to triethylamine. The silica gel column chromatography uses Qingdao ocean silica gel (particle size 0.040-0.063 mm). Thin Layer Chromatography (TLC) using 60F254 silica gel plates was performed using UV light (254 nm) or iodine.
Example 1
Synthesis of ceramide from avocado oil fatty acid and phytosphingosine
The first step: 50g of avocado oil and fat are dissolved in 60mL of tetrahydrofuran, cooled in an ice bath, 110mL of potassium hydroxide (25 wt%) solution is added dropwise, and the mixture is cooled to room temperature for reaction after the dropwise addition until TLC detection is completed.
Post-treatment: adding dilute hydrochloric acid (3N) to adjust the pH value of the reaction system to 3, adding 120mL of ethyl acetate to extract a water phase, adding 80mL of saturated saline water for washing once, and adding anhydrous Na into an organic phase 2 SO 4 Drying, filtration and concentration in vacuo gave 39g of avocado oil fatty acid.
And a second step of: avocado oil fatty acid (50 mmol based on main component fatty acid), EDCI (60 mmol), et 3 N (60 mmol) was added to a 250mL round bottom flask, followed by 80mL of dichloromethane, followed by stirring at room temperature for 1 hour, followed by phytosphingosine (60 mmol) added to the reaction system, and stirring at room temperature until TLC detection was complete.
Post-treatment: adding water for quenching reaction, separating an organic layer, drying, filtering and concentrating in vacuum, washing by a solvent to obtain avocado oil ceramide, and analyzing a product by HPLC (high performance liquid chromatography) under the condition of HPLC chromatography: using an shimadzu high performance liquid chromatograph (LC-2030 c 3 dplus) with Innoval ODS-2.6x250 mm,5 μm column temperature: 30 ℃, sample injection volume: 10 μl, flow rate: 1.0mL/min, evaporation temperature: 40 ℃, carrier gas flow rate: 2.5L/min, mobile phase: 100% methanol.
The retention time of each component HPLC was: palmitoleic acid-phytosphingosine ceramide 8.0min, linolenic acid-phytosphingosine ceramide 8.3min, linoleic acid-phytosphingosine ceramide 9.5min, palmitic acid-phytosphingosine ceramide 10.7min, oleic acid-phytosphingosine ceramide 11.3min, eicosapentaenoic acid-phytosphingosine ceramide 12.9min, stearic acid-phytosphingosine ceramide 13.9min.
The obtained products are analyzed by high performance liquid chromatography, and the content ratio of oleic acid-phytosphingosine ceramide, palmitoleic acid-phytosphingosine ceramide, linoleic acid-phytosphingosine ceramide, palmitic acid-phytosphingosine ceramide, stearic acid-phytosphingosine ceramide and linolenic acid-phytosphingosine ceramide is 70%, 10%, 7%, 8%, 1%, 0.5% and 0.5% in sequence, and the rest is other components, and the content is less.
Example 2
Synthesis of ceramide from avocado oil fatty acid and sphingosine
The first step: 50g of avocado oil and fat are dissolved in 60mL of tetrahydrofuran, cooled in an ice bath, 110mL of potassium hydroxide (25 wt%) solution is added dropwise, and the mixture is cooled to room temperature for reaction after the dropwise addition until TLC detection is completed.
Post-treatment: adding dilute hydrochloric acid (3N) to adjust the pH value of the reaction system to 3, adding 120mL of ethyl acetate to extract a water phase, adding 80mL of saturated saline water for washing once, and adding anhydrous Na into an organic phase 2 SO 4 Drying, filtration and concentration in vacuo gave 39.3g of avocado oil fatty acid.
And a second step of: avocado oil fatty acid (50 mmol based on main component fatty acid), EDCI (65 mmol), et 3 N (60 mmol) was added to a 250mL round bottom flask, followed by 100mL of dichloromethane, followed by stirring at room temperature for 1 hour, followed by sphingosine (55 mmol) added to the reaction system, and stirring at room temperature until TLC detection was complete.
Post-treatment: adding water for quenching reaction, separating an organic layer, drying, filtering and concentrating in vacuum, washing by a solvent to obtain avocado oil ceramide, and analyzing a product by HPLC (high performance liquid chromatography) under the condition of HPLC chromatography: using an shimadzu high performance liquid chromatograph (LC-2030 c 3 dplus) with Innoval ODS-2.6x250 mm,5 μm column temperature: 30 ℃, sample injection volume: 10 μl, flow rate: 1.0mL/min, evaporation temperature: 40 ℃, carrier gas flow rate: 2.5L/min, mobile phase: 100% methanol.
The retention time of each component HPLC was: linolenic acid-sphingosine ceramide 7.9min, palmitoleic acid-sphingosine ceramide 8.2min, linoleic acid-sphingosine ceramide 8.6min, oleic acid-sphingosine ceramide 10.2min, palmitic acid-sphingosine ceramide 10.5min, stearic acid-sphingosine ceramide 13.5min, arachidic acid-sphingosine ceramide 17.8min.
The obtained products are analyzed by high performance liquid chromatography, and the contents of oleic acid-sphingosine ceramide, palmitoleic acid-sphingosine ceramide, linoleic acid-sphingosine ceramide, palmitic acid-sphingosine ceramide, stearic acid-sphingosine ceramide, linolenic acid-sphingosine ceramide and arachidic acid-sphingosine ceramide are 52%, 8%, 19%, 16%, 2%, 0.5% and 1% in sequence, and the rest are other components, with smaller contents.
Example 3
Synthesis of ceramide from avocado oil fatty acid and sphinganine
The first step: 50g of avocado oil and fat are dissolved in 60mL of tetrahydrofuran, cooled in an ice bath, 110mL of potassium hydroxide (25 wt%) solution is added dropwise, and the mixture is cooled to room temperature for reaction after the dropwise addition until TLC detection is completed.
Post-treatment: adding dilute hydrochloric acid (3N) to adjust the pH value of the reaction system to 3, adding 120mL of ethyl acetate to extract a water phase, adding 80mL of saturated saline water for washing once, and adding anhydrous Na into an organic phase 2 SO 4 Drying, filtration and concentration in vacuo gave 39.2g of avocado oil fatty acid.
And a second step of: avocado oil fatty acid (50 mmol based on main component fatty acid), EDCI (70 mmol), et 3 N (65 mmol) was added to a 250mL round bottom flask, followed by 100mL of dichloromethane, followed by stirring at room temperature for 1 hour, followed by addition of sphinganine (65 mmol) to the reaction system, stirring at room temperature, and detection by TLC was complete.
Post-treatment: adding water for quenching reaction, separating an organic layer, drying, filtering and concentrating in vacuum, washing by a solvent to obtain avocado oil ceramide, and analyzing a product by HPLC (high performance liquid chromatography) under the condition of HPLC chromatography: using an shimadzu high performance liquid chromatograph (LC-2030 c 3 dplus) with Innoval ODS-2.6x250 mm,5 μm column temperature: 30 ℃, sample injection volume: 10 μl, flow rate: 1.0mL/min, evaporation temperature: 40 ℃, carrier gas flow rate: 2.5L/min, mobile phase: 100% methanol.
The retention time of each component HPLC was: linolenic acid-dihydrosphingosine ceramide 8.3min, palmitoleic acid-dihydrosphingosine ceramide 9.0min, linoleic acid-dihydrosphingosine ceramide 9.5min, palmitic acid-dihydrosphingosine ceramide 10.6min, oleic acid-dihydrosphingosine ceramide 11.2min, stearic acid-dihydrosphingosine ceramide 13.5min, eicosapentaenoic acid-dihydrosphingosine ceramide 14.0min, arachidic acid-dihydrosphingosine ceramide 16.0min.
The obtained products are analyzed by high performance liquid chromatography, the content of oleic acid-dihydrosphingosine ceramide, palmitoleic acid-dihydrosphingosine ceramide, linoleic acid-dihydrosphingosine ceramide, palmitic acid-dihydrosphingosine ceramide, stearic acid-dihydrosphingosine ceramide, linolenic acid-dihydrosphingosine ceramide, arachidic acid-dihydrosphingosine ceramide and eicosapentaenoic acid-dihydrosphingosine ceramide is 61%, 20%, 6%, 7%, 1%, 0.5% and 0.5% in sequence, and the rest is other components, and the content is less.
Example 4
Assessment of skin barrier repair by cell migration
Principle of: when the cells grow to be fused into a single-layer state, a scratch tool is manufactured on the fused single-layer cells, the cells in the blank area are removed by mechanical force, the migration condition of the cells to the cell-free area is observed through a period of culture, and the migration capability of the cells is reflected by measuring the migration distance of the cells.
The operation steps are as follows:
1. the culture plate is streaked. Firstly, a Marker pen is used for uniformly scribing transverse lines by comparing with a straight ruler, and the transverse lines are crossed through the through holes at intervals of about 0.5 cm to 1cm, and each hole at least passes through 5 lines, so that attention lines are not too thick when scribing.
2. And (5) paving cells. About 5X 10 is added to the well 5 Individual cells (the number of different cells is different, and the cell growth speed is regulated), and the inoculation principle is that the fusion rate reaches 100% after overnight.
3. Cell streaking. The next day the tip is used to scratch the cell layer along the line marked on the back of the plate on the first day, perpendicular to the cell plane (the same tip is preferably used between the different wells).
4. Washing cells. After the streaking was completed, cells were washed 3 times with sterile PBS, cells that did not adhere to the wall, i.e., streaked cells at streaking, and the gap left after streaking was clearly visible, followed by replacement of fresh serum-free medium.
5. And (5) culturing and observing the cells. Sample (example 1 product)After dilution of the product, ceramide 3B, with the medium (product concentration of example 1: 50mg/L, ceramide 3B concentration: 100 mg/L) was added to a cell culture dish, and the cells were placed in 5wt% CO at 37 ℃C 2 Incubator culture, after 24 hours, cells were removed, observed with a microscope and the width of scratches was measured, and photographed, and the healing rate was calculated using Image J software.
The results are shown in figure 1, which shows that the scratch width of the experimental group is narrower than that of the solvent control group, thus indicating that avocado oil ceramide has better tissue healing capacity. The solvent control group had a rate of 35.23% after 24 hours, avocado oleoyl ceramide had a rate of 62.71% after 24 hours, and ceramide 3B had a rate of 59.32% after 24 hours. The compound obviously improves the cell healing rate, has good skin tissue repair activity and has better effect than ceramide 3B.
Example 5
Elastase inhibition experiment tests anti-aging effect
Elastase inhibition method: 2mg/mL elastase solution (product of example 1) is taken, samples with different concentrations (2 mL) are added, vortex mixing is carried out fully, shaking is carried out for 20min at 37 ℃ by a 400r/min shaking table, 5mL of 0.5mol/L phosphate buffer solution with pH of 6.0 is added immediately, vortex mixing is carried out, a proper amount of mixed solution is taken into a 2mL centrifuge tube, centrifugation is carried out for 10min at 9 391×g, 200 mu L of supernatant is sucked into a 96-well plate precisely, absorbance is measured by an enzyme-labeled instrument at a wavelength of 495nm, and spectrum scanning at 400-800 nm is carried out simultaneously.
The substrate enzyme adding solution is used as a blank control group, the substrate enzyme adding and sample solution is used as an enzyme inhibition group, and the substrate enzyme adding and sample solution is used as a background. Each group is provided with 3 multiple holes. Inhibition ratio (%) = [1- (An-An ')/(A0-A0') ] ×100%, where A0 is absorbance with no enzyme added to the sample, A0 'is absorbance with no enzyme added to the substrate and no sample added to the enzyme, an is absorbance with only sample solution, an' is absorbance with no enzyme added to the sample. When An ' > An, the effect is expressed as acceleration, and the acceleration rate (%) = [1- (An ' -An)/(A0-A0 ') ] ×100%.
As shown in FIG. 2, avocado oil ceramide has a good inhibitory effect on elastase at various concentrations, specifically, an inhibitory rate of 11.47% on elastase at a concentration of 0.25g/L, an inhibitory rate of 18.33% on elastase at a concentration of 0.5g/L, an inhibitory rate of 25.27% on elastase at a concentration of 1.0g/L, and an inhibitory rate of 25.33% on elastase at a concentration of 2.0 g/L.
Example 6
LPS induced cell method for detecting anti-inflammatory repair efficacy
B16 mouse melanoma cells were grown at a density of 1X 10 4 The cells/wells were seeded in 96-well plates, placed in an incubator overnight, the supernatant was discarded after 24 hours, 100. Mu.L of samples of different concentrations diluted with DMEM medium (product of example 1) were added, the negative control group was DMEM medium without samples, 3 wells per group, and mixed with CO at 5 wt.% 2 Incubate at 37 ℃. Lipopolysaccharide model group and experimental group were added with 10 μg/mL LPS and incubated together for 24h 2h after dosing. After the reaction, 50. Mu.L of the cell supernatant was collected, and the intracellular IL-6 gene expression was detected using an IL-6ELISA kit.
The results are shown in FIG. 3, where IL-6 levels were 10.16 times the basal levels at a working concentration of 10. Mu.g/mL of LPS stimulation. Under the action of avocado oil ceramide with the concentration of 50mg/L, 100mg/L, 200mg/L and 400mg/L respectively, the IL-6 factor level is obviously reduced and is 1.07, 0.77, 0.80 and 0.67 times of that of an LPS model group respectively, and the avocado oil ceramide is dose-dependent, which proves that the avocado oil ceramide has good anti-inflammatory effect and can promote the repair of inflammatory damaged skin.
Example 7
MMP1 is also called interstitial collagenase and matrix metalloproteinase, belongs to matrix metalloproteinase family, and its main acting substrate is fibrous collagen, which can degrade collagen fiber and gelatin in extracellular matrix and change microenvironment of cells. MMP1 plays an important role in elastin, inhibiting MMP1 can improve the synthesis of fibroblast collagen and elastin, and reducing MMP activity can increase the collagen synthesis speed.
HaCaT cells were grown at 1X 10 5 The density of individuals/wells was seeded in 96-well plates and the incubator was overnight. After 24 hours, the supernatant was discarded and samples containing different concentrations were added (example 1 productSubstance) of the culture medium 100 μl, no sample was added to the model group, the negative control group was DMEM medium without sample, 3 wells per group, and the mass fraction of CO was 5% 2 After incubation for 2h at 37℃either UVA or UVB ultraviolet radiation is irradiated. The distance between the ultraviolet radiation source and the cells was 15cm, and the UVA intensity was 200mJ/cm 2 The irradiation time was 2 hours, and the UVB intensity was 50mJ/cm 2 The irradiation time was 1h. After the end of irradiation, incubation was continued for 12h in the incubator. Intracellular MMP-1 gene expression was detected using an MMP-1ELISA kit. Inhibition = 1- (experimental group MMP1 expression level/model group MMP1 expression level) ×100%.
As shown in fig. 4 and 5, the expression level of MMP1 in the negative control group was 1, the expression level in the model group was 1.90, and the inhibition ratio of MMP1 expression in the model group was 17%, 32%, 45% at the concentrations of 125, 250, 400mg/L of avocado oil ceramide; for UVB, the MMP1 expression level of the negative control group was 1, the expression level of the model group was 2.33, and the inhibition rate of MMP1 expression was 34%, 44% and 55% relative to the model group at the concentrations of 125, 250 and 400mg/L of avocado oil ceramide.
After UVA uv radiation, keratinocytes promote elevated expression of MMP1 by fibroblasts, thereby causing degradation of the extracellular matrix of the skin and collagen of the skin, leading to photoaging of the skin. The results show that avocado oil ceramide can inhibit the fibroblast from producing MMP1 caused by ultraviolet radiation, and has a certain effect on preventing skin photoaging.
Example 8
DPPH free radical scavenging detection of antioxidant performance
DPPH is 1, 1-diphenyl-2-trinitrophenylhydrazine, and can be used for antioxidant experiments.
Samples (product of example 1) at corresponding concentrations (50, 100, 200, 400, 800 mg/L) were mixed with 0.1mol/L DPPH, absolute ethanol solution at a ratio of 1:1, and DPPH and absolute ethyl alcohol 1:1, and the absorbance at 517 nm. The absorbance of the sample and the reaction solution of DPPH was designated as A1, the absorbance of the sample and the reaction solution of absolute ethyl alcohol was designated as A2, the absorbance of the reaction solution of DPPH and absolute ethyl alcohol was designated as A3, and the clearance rate of DPPH of the sample was = [1- (A1-A2)/A3 ]. Times.100%.
As a result, as shown in FIG. 6, the DPPH radical scavengers at concentrations of 50, 100, 200, 400 and 800mg/L were 7.09%, 12.40%, 18.73%, 23.77% and 27.44%, respectively, and excellent antioxidant effects were exhibited.
Example 9
Whitening Activity test
Taking B16 cells in exponential growth phase, digesting with trypsin-EDTA with mass fraction of 0.25%, blowing uniformly, and mixing the cells according to 3×10 5 Density of individual/well was seeded in 12-well plates. At 37 ℃, the mass fraction of CO is 5 percent 2 Incubated overnight in the environment. Removing supernatant, adding culture solution containing samples with different mass concentrations (product of example 1), incubating with RPMI-1640 culture medium without sample as blank group, incubating with DMEM culture medium as mould group, and incubating with 3 compound holes in each group at mass fraction of 5% CO 2 Incubation was carried out for 24h at 37 ℃. The culture medium in the well plate is discarded, and after washing with Phosphate Buffer (PBS) for one to two times, 1mL of NaOH solution (1 mol/L) containing 10% DMSO by mass fraction is added to lyse the cells, and the cells are kept at a constant temperature of 80℃or 100℃for 2 hours until the cells are completely lysed. The absorbance was measured at 405nm in a microplate reader. The melanin inhibition rate=1- (OD value per well/OD value of model group) ×100% was calculated.
As a result, as shown in FIG. 7, the melanin content of the blank group was 1, the melanin expression of the model group was 1.51, and the melanin inhibition rates of avocado oil ceramide were 4.58%, 10.70%, 15.95%, 19.30% and 20.98% at concentrations of 10, 20, 40, 80 and 100mg/L, respectively, and a good whitening effect was exhibited.
The foregoing is merely illustrative embodiments of the present invention, and the present invention is not limited thereto, and any changes or substitutions that may be easily contemplated by those skilled in the art within the scope of the present invention should be included in the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the protection scope of the claims.
Claims (10)
1. Avocado oil ceramide, which is obtained by reacting avocado oil fatty acids with a sphingoid compound selected from the group consisting of sphingosine, phytosphingosine, dihydrosphingosine.
2. The avocado oil ceramide of claim 1, wherein the avocado oil fatty acid is obtained by hydrolysis of avocado oil.
3. Avocado oil ceramide according to claim 1 or 2, characterized in that the avocado oil fatty acid contains 50-80 wt.% oleic acid, 5-25 wt.% palmitoleic acid, 5-20 wt.% linoleic acid, 6-18 wt.% palmitic acid, 0.1-2 wt.% stearic acid, 0.1-1 wt.% linolenic acid.
4. Avocado oil ceramide, which comprises the following components: oleic acid ceramide, palmitoleic acid ceramide, linoleic acid ceramide, palmitic acid ceramide, stearic acid ceramide, linolenic acid ceramide.
5. The avocado oil ceramide of claim 4, comprising the composition of: 50 to 80 weight percent of oleic acid ceramide, 5 to 25 weight percent of palmitoleic acid ceramide, 5 to 20 weight percent of linoleic acid ceramide, 6 to 18 weight percent of palmitic acid ceramide, 0.1 to 2 weight percent of stearic acid ceramide and 0.1 to 1 weight percent of linolenic acid ceramide.
6. The avocado oil ceramide of claim 4 or 5, further comprising: 0 to 1 weight percent of arachidic acid ceramide and 0 to 0.5 weight percent of eicosapentaenoic acid ceramide.
7. The method for synthesizing avocado oil ceramide according to any one of claims 1 to 6, comprising the steps of:
under the conditions of condensing agent and organic base, the avocado oil fatty acid reacts with sphingosine compound, the condensing agent is EDCI, and the organic base is Et 3 N;
The avocado oil fatty acid, sphingosine compound, EDCI, et 3 The molar ratio of N is 1:(1-1.5): (1-2): (1-2), wherein the solvent for the reaction is at least one of dichloromethane, tetrahydrofuran, ethyl acetate and acetonitrile.
8. Use of avocado oil ceramide as defined in any one of claims 1 to 6 in cosmetics, pharmaceuticals, dietary or health products.
9. The use according to claim 8, wherein the avocado oil ceramide has at least one of skin barrier repair, tissue healing, anti-aging, anti-inflammatory, anti-photoaging, antioxidant, promoting collagen synthesis, maintaining elastin viability, whitening efficacy.
10. A composition comprising the avocado oil ceramide of any one of claims 1-6, having at least one of skin barrier repair, tissue healing, anti-aging, anti-inflammatory, anti-photoaging, antioxidant, promoting collagen synthesis, maintaining elastin viability, whitening efficacy.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310051748.3A CN116023289A (en) | 2023-02-02 | 2023-02-02 | Avocado oil ceramide and synthesis method and application thereof |
PCT/CN2023/133524 WO2024109867A1 (en) | 2022-11-25 | 2023-11-23 | Vegetable oil ceramides, synthesis method therefor, and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310051748.3A CN116023289A (en) | 2023-02-02 | 2023-02-02 | Avocado oil ceramide and synthesis method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116023289A true CN116023289A (en) | 2023-04-28 |
Family
ID=86091207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310051748.3A Pending CN116023289A (en) | 2022-11-25 | 2023-02-02 | Avocado oil ceramide and synthesis method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116023289A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024109867A1 (en) * | 2022-11-25 | 2024-05-30 | 深圳市迪克曼生物科技有限公司 | Vegetable oil ceramides, synthesis method therefor, and use thereof |
-
2023
- 2023-02-02 CN CN202310051748.3A patent/CN116023289A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024109867A1 (en) * | 2022-11-25 | 2024-05-30 | 深圳市迪克曼生物科技有限公司 | Vegetable oil ceramides, synthesis method therefor, and use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115974714A (en) | Shea butter ceramide, and its synthesis method and use | |
CN115947666A (en) | Rice bran oil ceramide and synthesis method and application thereof | |
CN1905886B (en) | A composition containing ginsenoside F1 or compound K for skin external application | |
CN115894279A (en) | Olive oil ceramide and synthesis method and application thereof | |
KR101404398B1 (en) | Anti-wrinkle cosmetic composition | |
KR100435855B1 (en) | Composition for external application to the skin containing Opuntia ficus-indica extract | |
JP4939766B2 (en) | Basement membrane stabilizer | |
CN116023289A (en) | Avocado oil ceramide and synthesis method and application thereof | |
CN115304509A (en) | Ceramide compound containing chain carboxylic acid and preparation method and application thereof | |
KR20200092625A (en) | A cosmetic composition comprising a fermented extract of Hemp Seed as an active ingredient | |
CN116003287A (en) | Sunflower seed oil ceramide and synthesis method and application thereof | |
CN116041206A (en) | Safflower seed oil ceramide and its synthesis method and use | |
CN116003289A (en) | Watermelon seed oil ceramide and synthesis method and application thereof | |
CN116023288A (en) | Grape seed oil ceramide and synthesis method and application thereof | |
CN116003288A (en) | Nanmei oleo ceramide and its synthesis method and use | |
CN116003286A (en) | Prinsepia utilis royle oil ceramide and synthesis method and application thereof | |
CN116041205A (en) | Borage oil ceramide and synthetic method and application thereof | |
CN115974715A (en) | Peony seed oil ceramide, and synthesis method and application thereof | |
CN115974716A (en) | Cottonseed oil ceramide and synthesis method and application thereof | |
CN115947667A (en) | Coconut oil ceramide and synthesis method and application thereof | |
JP2009221110A (en) | Basement membrane stabilizer | |
CN117304059A (en) | Tomato seed oil ceramide and synthetic method and application thereof | |
CN117326967A (en) | Pterocarpus santalinus seed oil ceramide and synthesis method and application thereof | |
CN117304055A (en) | Perilla seed oil ceramide and synthesis method and application thereof | |
CN117285433A (en) | Nut oil ceramide and synthesis method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |